Genetics & Genomics

Pharmacogenomics: Why Standard Codeine Doses Can Have Serious Toxicities or No Therapeutic Effect

Patricia A. Kelly

pharmacogenomics, toxic
ONF 2013, 40(4), 322-324. DOI: 10.1188/13.ONF.322-324

Three children died in August 2012 after receiving usual doses of codeine for postoperative pain following a tonsillectomy and/or adenoidectomy (U.S. Food and Drug Administration [FDA], 2013a). Those incidents, combined with a case report of a breast-feeding infant who died in 2005 of an apparent overdose after the mother received a standard dose of codeine for episiotomy pain (Health Sciences Authority, 2009; Koren, Cairns, Chitayat, Gaedigk, & Leeder, 2006), heighten the need to understand the pharmacogenomics of codeine metabolism.

Jump to a section

    References

    Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D.D, Callaghan, J. T., … Skaar, T. C. (2012). Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clinical Pharmacology and Therapeutics, 91, 321-326. doi:10.1038/cipt.2011.287
    Genetics Home Reference. (2013a). CYP2D6. Retrieved from http://ghr.nlm.nih.gov/gene/CYP2D6
    Genetics Home Reference. (2013b). Gene amplification. Retrieved from http://ghr.nlm.nih.gov/glossary=geneamplification
    Health Sciences Authority. (2009). Codeine toxicity in breastfed infants. Retrieved from http://bit.ly/15vmJp5
    Howe, L. A., & Eggert, J. (2007). Influence of pharmacogenomics on disease and symptom management. International Journal of Nursing in Intellectual and Developmental Disabilities. Retrieved from http://ddna.org/vol3_issue2_article02 http://ddna.org/vol3_issue2_article02
    Kelly, P. (2007). Genes and codeine: What's the connection? Cancer Genetics Special Interest Group Newsletter. Retrieved from http://onsopcontent.ons.org/Publications/SIGNewsletters/cg/cg11.3.html http://onsopcontent.ons.org/Publications/SIGNewsletters/cg/cg11.3.html
    Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., & Leeder, S. J. (2006). Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet, 368, 704. doi:10.1016/S0140-6736(06)69255-6
    PharmGKB. (2012). CPIC dosing guideline for codeine and CYP2D6. Retrieved from www.pharmgkb.org/drug/PA449088
    Sheffield, L. J., & Phillimore, H. E. (2009). Clinical use of pharmacogenomic tests in 2009. Clinical Biochemist. Reviews, 30(2), 55-65.
    U. S. Department of Energy Human Genome Programs. (2011). Human genome project information: Pharmacogenomics. Retrieved from http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml
    U. S. Food and Drug Administration. (2008). Pharmacogenomics and its role in drug safety. FDA drug safety newsletter. Retrieved from http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm119991.htm
    U. S. Food and Drug Administration. (2010). Information for healthcare professionals: Use of codeine products in nursing mothers. Retrieved from http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm124889.htm
    U. S. Food and Drug Administration. (2013a). Codeine use in certain children after tonsillectomy and/or adenoidectomy: Drug safety communication—Risk of rare, but life-threatening adverse events or death. Retrieved from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315627.htm
    U. S. Food and Drug Administration. (2013b). FDA drug safety communication: Safety review update of codeine use in children; new boxed warning and contraindication on use after tonsillectomy and/or adenoidectomy. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm
    U. S. Food and Drug Administration. (2013c). For consumers: Warning for nursing mothers taking codeine. Retrieved from http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048740.htm